Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Florman

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2007
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipientsT G Heffron, M D Pescovitz, S Florman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 27, 2010
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)A Durrbach, J M Pestana, T Pearson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 1, 2016
Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized StudyA Durrbach, J M Pestana, S Florman, et al.
Frontiers in Bioengineering and Biotechnology|June 30, 2023
Sustained in vivo perfusion of a re-endothelialized tissue engineered kidney graft in a human-scale animal modelJoseph S Uzarski, Emily C Beck, Emily E Russell, et al.
Plos Pathogens|July 30, 2019
Individual liver plasmacytoid dendritic cells are capable of producing IFNα and multiple additional cytokines during chronic HCV infectionErin Heather Doyle, Adeeb Rahman, Costica Aloman, et al.
Kidney International|October 3, 2017
Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survivalRabi Yacoub, Girish N Nadkarni, Paolo Cravedi, et al.
Surgery|September 4, 2012
Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipientsJack Harbell, John Fung, Nicholas Nissen, et al.
Journal of Hepatology|September 10, 2024
Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY studyParissa Tabrizian, Matthew L Holzner, Veeral Ajmera, et al.
Annals of Surgery|August 29, 2001
One hundred nine living donor liver transplants in adults and children: a single-center experienceC M Miller, G E Gondolesi, S Florman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 5, 2003
Calicivirus enteritis in an intestinal transplant recipientStuart S Kaufman, Nando K Chatterjee, Meghan E Fuschino, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2007
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipientsT G Heffron, M D Pescovitz, S Florman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 27, 2010
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)A Durrbach, J M Pestana, T Pearson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 1, 2016
Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized StudyA Durrbach, J M Pestana, S Florman, et al.
Frontiers in Bioengineering and Biotechnology|June 30, 2023
Sustained in vivo perfusion of a re-endothelialized tissue engineered kidney graft in a human-scale animal modelJoseph S Uzarski, Emily C Beck, Emily E Russell, et al.
Plos Pathogens|July 30, 2019
Individual liver plasmacytoid dendritic cells are capable of producing IFNα and multiple additional cytokines during chronic HCV infectionErin Heather Doyle, Adeeb Rahman, Costica Aloman, et al.
Kidney International|October 3, 2017
Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survivalRabi Yacoub, Girish N Nadkarni, Paolo Cravedi, et al.
Surgery|September 4, 2012
Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipientsJack Harbell, John Fung, Nicholas Nissen, et al.
Journal of Hepatology|September 10, 2024
Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY studyParissa Tabrizian, Matthew L Holzner, Veeral Ajmera, et al.
Annals of Surgery|August 29, 2001
One hundred nine living donor liver transplants in adults and children: a single-center experienceC M Miller, G E Gondolesi, S Florman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 5, 2003
Calicivirus enteritis in an intestinal transplant recipientStuart S Kaufman, Nando K Chatterjee, Meghan E Fuschino, et al.
Pageof 12